KLP Kapitalforvaltning AS Has $4.95 Million Position in The Cooper Companies, Inc. $COO

KLP Kapitalforvaltning AS boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,500 shares of the medical device company’s stock after acquiring an additional 1,300 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Cooper Companies were worth $4,946,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Hardy Reed LLC raised its holdings in shares of Cooper Companies by 4.1% in the second quarter. Hardy Reed LLC now owns 6,213 shares of the medical device company’s stock valued at $442,000 after buying an additional 244 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cooper Companies by 8.3% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 28,350 shares of the medical device company’s stock worth $2,017,000 after buying an additional 2,161 shares during the last quarter. Lecap Asset Management Ltd. boosted its holdings in Cooper Companies by 16.3% during the second quarter. Lecap Asset Management Ltd. now owns 24,034 shares of the medical device company’s stock worth $1,710,000 after buying an additional 3,372 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its holdings in Cooper Companies by 9.8% during the second quarter. Robeco Institutional Asset Management B.V. now owns 17,686 shares of the medical device company’s stock worth $1,259,000 after buying an additional 1,578 shares during the last quarter. Finally, LBP AM SA boosted its holdings in Cooper Companies by 79.2% during the second quarter. LBP AM SA now owns 125,325 shares of the medical device company’s stock worth $8,918,000 after buying an additional 55,391 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Insider Activity at Cooper Companies

In related news, COO Daniel G. Mcbride acquired 3,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the purchase, the chief operating officer directly owned 63,120 shares in the company, valued at approximately $4,105,324.80. This trade represents a 4.99% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian G. Andrews acquired 1,525 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average price of $65.68 per share, for a total transaction of $100,162.00. Following the purchase, the executive vice president owned 22,191 shares in the company, valued at approximately $1,457,504.88. This represents a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 17,975 shares of company stock worth $1,216,346. Insiders own 1.98% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on COO shares. Robert W. Baird reduced their target price on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating on the stock in a report on Thursday, August 28th. Weiss Ratings restated a “hold (c-)” rating on shares of Cooper Companies in a report on Wednesday. Loop Capital set a $100.00 price objective on Cooper Companies in a report on Tuesday, June 17th. Piper Sandler cut their price objective on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a report on Thursday, August 28th. Finally, UBS Group upgraded Cooper Companies to a “buy” rating in a report on Tuesday, June 17th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus target price of $84.75.

Cooper Companies Stock Down 2.0%

Shares of Cooper Companies stock opened at $68.37 on Friday. The business’s 50 day simple moving average is $69.43 and its 200 day simple moving average is $73.73. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $109.37. The firm has a market cap of $13.59 billion, a PE ratio of 33.68, a P/E/G ratio of 1.83 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the firm earned $0.96 EPS. Cooper Companies’s revenue for the quarter was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share repurchase program on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.